Medical News

RSS

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

19 Jul 2013

Metabolomics tools predict who can benefit from treatment with certain antidepressants

Duke Medicine researchers have identified biochemical changes in people taking antidepressants - but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes.

19 Jul 2013

Early diagnosis of AD may prevent psychological and behavioral symptoms

Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.

19 Jul 2013

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.

19 Jul 2013

Anacor presents Phase 3 safety and efficacy results of Tavaborole for treatment of onychomycosis

Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its abstract "Pivotal Phase 3 Safety and Efficacy Results of Tavaborole (Formerly AN2690), a Novel Boron-Based Molecule for the Topical Treatment of Toenail Onychomycosis" was accepted for oral presentation at the 2013 APMA Annual Scientific Meeting (The National) to be held in Las Vegas, Nevada.

19 Jul 2013

Scientists discover molecular switch that determines death or survival of cell

The study is the result of a collaboration of scientists at Karolinska Institutet in Sweden, University of Michigan, and University of California San Diego, USA, who were interested in finding out whether autophagy can be affected by events in the cell nucleus. Surprisingly, they discovered that a signal chain in the nucleus serves as a kind of molecular switch that determines whether the cell dies or survives.

19 Jul 2013

Depressive disorder patients exhibit negative bias brain imaging changes and cognitive dysfunction

...

19 Jul 2013

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

19 Jul 2013

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

Kansas State University researchers are defeating persistent bacteria known for causing infections in hospitals.

19 Jul 2013

WuXi buys Provantis Portal Remote Study Monitoring solution from Instem

Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WuXi AppTec, a leading supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, has purchased the Provantis Portal Remote Study Monitoring solution.

19 Jul 2013

Cubist initiates bevenopran Phase 3 studies in patients with chronic non-cancer pain and OIC

Cubist Pharmaceuticals, Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain and opioid-induced constipation.

19 Jul 2013

Spinal Restoration: Success criteria not met for primary analysis of Phase III study of Biostat System

Spinal Restoration, Inc. announced today that the success criteria for primary analysis of the Phase III Investigational New Drug study of the Biostat System were not met. The proportions of successful patients that received BIOSTAT BIOLOGX Fibrin Sealant or saline injection were not statistically significantly different when analyzed at the 26-week primary endpoint.

19 Jul 2013

Research shows split liver transplantation carries no increased risk of failure in either recipient

Split liver transplantation carries no increased risk of failure in either recipient, allowing surgeons to safely save two lives from a single donated organ (graft), according to new research from Boston Children's Hospital published online in the Journal of the American College of Surgeons.

19 Jul 2013

Health law supporters hail N.Y. announcement that insurance rates will drop

Gov. Andrew Cuomo announced Wednesday that premiums for health policies purchased by individuals in the state's new online marketplace will fall on average 50 percent in 2014.

19 Jul 2013

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

HCA and IASIS Healthcare LLC today announced the signing of a definitive agreement for the sale of three Tampa Bay hospitals—Palms of Pasadena Hospital, Memorial Hospital of Tampa and Town & Country Hospital—by IASIS to HCA West Florida.

19 Jul 2013

"Hometown Mission," Cedars-Sinai surgical teams perform free surgery for poor children

The "little purple lump" appeared in front of Angela Huerta's left ear about six months ago, surprising the 9-year-old girl and worrying her mother. The freckle-sized cyst ached and interfered with her school work.

19 Jul 2013

Idera Pharmaceuticals receives patent related to IMO-8400

Idera Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has issued to Idera patent number 8,486,908, providing both composition of matter and method of use protection for IMO-8400.

19 Jul 2013

Researchers identify genetic cause of severe obesity

Researchers at Boston Children's Hospital have identified a genetic cause of severe obesity that, though rare, raises new questions about weight gain and energy use in the general obese population. The research, published in the journal Science on July 19, involved genetic surveys of several groups of obese humans and experiments in mice.

19 Jul 2013

Three key technologies receive £85 million investment for capital equipment from EPSRC

Three key technologies, identified in the pre-budget statement by The Chancellor of the Exchequer as part of the government's 'eight great technologies' to drive UK growth, are to receive an -85 million investment for capital equipment.

19 Jul 2013

FDA grants orphan drug designation to ARMAGEN's AGT-182 for treatment of Hunter syndrome

ARMAGEN announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product AGT-182 for the treatment of mucopolysaccharidosis type II (also known as Hunter syndrome or MPS II).

19 Jul 2013

Medical News

C. difficile bacteriophage provides new weapon to battle against superbugs

Metabolomics tools predict who can benefit from treatment with certain antidepressants

Early diagnosis of AD may prevent psychological and behavioral symptoms

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Anacor presents Phase 3 safety and efficacy results of Tavaborole for treatment of onychomycosis

Scientists discover molecular switch that determines death or survival of cell

Depressive disorder patients exhibit negative bias brain imaging changes and cognitive dysfunction

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

Kansas researchers defeat persistent bacteria known for causing infections in hospitals

WuXi buys Provantis Portal Remote Study Monitoring solution from Instem

Cubist initiates bevenopran Phase 3 studies in patients with chronic non-cancer pain and OIC

Spinal Restoration: Success criteria not met for primary analysis of Phase III study of Biostat System

Research shows split liver transplantation carries no increased risk of failure in either recipient

Health law supporters hail N.Y. announcement that insurance rates will drop

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

"Hometown Mission," Cedars-Sinai surgical teams perform free surgery for poor children

Idera Pharmaceuticals receives patent related to IMO-8400

Researchers identify genetic cause of severe obesity

Three key technologies receive £85 million investment for capital equipment from EPSRC

FDA grants orphan drug designation to ARMAGEN's AGT-182 for treatment of Hunter syndrome

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News